Up to now the impact of γ-secretase inhibitors on the differentiation of colonic cancer cells has been evaluated only on the basis of MUC2 gene expression [1], [37], without taking into account the fact that colonic cancer cells ectopically express the MUC5AC gastric mucin [18]. The gene discussed is MUC2; the disease is malignant colon neoplasm.